SCHEMBL8970175

SCHEMBL8970175

Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(O)OP(=O)(O)O)[C@@H](O)[C@H]1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.59
P2RY2 P41231 4/20 0.56
P2RY1 P47900 4/20 0.56
ADORA1 P30542 2/20 0.56
SRC P12931 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
DNPH1 O43598 1/20 0.56
PRKAB2 O43741 1/20 0.56
TRPM2 O94759 1/20 0.56
LDHA P00338 1/20 0.56
ADRB2 P07550 1/20 0.56
FBP1 P09467 1/20 0.56
PRKAG1 P54619 1/20 0.56
PRKAA2 P54646 1/20 0.56
PDE4D Q08499 1/20 0.56
KCNH2 Q12809 1/20 0.56
PRKAA1 Q13131 1/20 0.56
PDE3A Q14432 1/20 0.56
TAS1R3 Q7RTX0 1/20 0.56
TAS1R1 Q7RTX1 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9853314 1.00 NT5E (0.59) NT5EP2RY2P2RY1ADORA1SRC
SCHEMBL8862998 1.00 NT5E (0.59) NT5EP2RY2P2RY1ADORA1SRC
SCHEMBL756245 0.91 P2RY2 (0.64) P2RY2P2RY1ADORA1SRCSMN1; SMN2
Water SCHEMBL443839 0.90 P2RY2 (0.63) P2RY2P2RY1ADORA1SRCSMN1; SMN2
SCHEMBL8836780 0.89 GK (0.57) NT5EP2RY2P2RY1ADORA1SRC
SCHEMBL8836084 0.85 NT5E (0.60) NT5EP2RY2P2RY1ADORA1SRC
SCHEMBL8836065 0.85 NT5E (0.60) NT5EP2RY2P2RY1ADORA1SRC
SCHEMBL27120145 0.83 AHCY (0.58) NT5EADORA1SMN1; SMN2AHCYADORA2A
SCHEMBL3164897 0.83 P2RY2 (0.65) P2RY2P2RY1ADORA1SRCSMN1; SMN2
SCHEMBL9395428 0.82 NT5E (0.57) NT5EP2RY2P2RY1ADORA1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0417999-B1 Antiviral compounds WELLCOME FOUND (GB) 1996-03-13 EP disclosed
EP-0671410-A1 Antiviral compounds THE WELLCOME FOUNDATION LIMITED (GB) 1995-09-13 EP disclosed
US-5420115-A Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides BURROUGHS WELLCOME CO. (US) 1995-05-30 US disclosed
EP-0417999-A1 Antiviral compounds THE WELLCOME FOUNDATION LIMITED (GB) 1991-03-20 EP disclosed